{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T18:51:54Z","timestamp":1791312714016,"version":"4.3.1"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,5,18]],"date-time":"2021-05-18T00:00:00Z","timestamp":1621296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,5,18]],"date-time":"2021-05-18T00:00:00Z","timestamp":1621296000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["1R01AR069107"],"award-info":[{"award-number":["1R01AR069107"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["HL127339"],"award-info":[{"award-number":["HL127339"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000968","name":"American Heart Association","doi-asserted-by":"publisher","award":["TPA2035490150"],"award-info":[{"award-number":["TPA2035490150"]}],"id":[{"id":"10.13039\/100000968","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Fibrosis is a hallmark of heart disease independent of etiology and is thought to contribute to impaired cardiac dysfunction and development of heart failure. However, the underlying mechanisms that regulate the differentiation of fibroblasts to myofibroblasts and fibrotic responses remain incompletely defined. As a result, effective treatments to mitigate excessive fibrosis are lacking. We recently demonstrated that the Hippo pathway effector Yes-associated protein (YAP) is an important mediator of myofibroblast differentiation and fibrosis in the infarcted heart. Yet, whether YAP activation in cardiac fibroblasts is sufficient to drive fibrosis, and how fibroblast YAP affects myocardial inflammation, a significant component of adverse cardiac remodeling, are largely unknown. In this study, we leveraged adeno-associated virus (AAV) to target cardiac fibroblasts and demonstrate that chronic YAP expression upregulated indices of fibrosis and inflammation in the absence of additional stress. YAP occupied the <jats:italic>Ccl2<\/jats:italic> gene and promoted Ccl2 expression, which was associated with increased macrophage infiltration, pro-inflammatory cytokine expression, collagen deposition, and cardiac dysfunction in mice with cardiac fibroblast-targeted YAP overexpression. These results are consistent with other recent reports and extend our understanding of YAP function in modulating fibrotic and inflammatory responses in the heart.<\/jats:p>","DOI":"10.1038\/s41598-021-89989-5","type":"journal-article","created":{"date-parts":[[2021,5,18]],"date-time":"2021-05-18T10:06:23Z","timestamp":1621332383000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":61,"title":["AAV-mediated YAP expression in cardiac fibroblasts promotes inflammation and increases fibrosis"],"prefix":"10.1038","volume":"11","author":[{"given":"Jamie","family":"Francisco","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuki","family":"Nakada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jae Im","family":"Jeong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun-Yang","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Ivessa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinichi","family":"Oka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gopal J.","family":"Babu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominic P.","family":"Del Re","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,5,18]]},"reference":[{"key":"89989_CR1","unstructured":"Frangogiannis, N. G. Cardiac fibrosis. Cardiovasc. Res. Cvaa324 (2020)."},{"key":"89989_CR2","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.cophys.2017.08.002","volume":"1","author":"MD Tallquist","year":"2018","unstructured":"Tallquist, M. D. Cardiac fibroblasts: From origin to injury. Curr. Opin. Physiol. 1, 75\u201379 (2018).","journal-title":"Curr. Opin. Physiol."},{"key":"89989_CR3","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.yjmcc.2017.11.012","volume":"114","author":"MJ Ivey","year":"2018","unstructured":"Ivey, M. J. et al. Resident fibroblast expansion during cardiac growth and remodeling. J. Mol. Cell Cardiol. 114, 161\u2013174 (2018).","journal-title":"J. Mol. Cell Cardiol."},{"key":"89989_CR4","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1016\/j.devcel.2012.08.017","volume":"23","author":"J Davis","year":"2012","unstructured":"Davis, J., Burr, A. R., Davis, G. F., Birnbaumer, L. & Molkentin, J. D. A TRPC6-dependent pathway for myofibroblast transdifferentiation and wound healing in vivo. Dev. Cell 23, 705\u2013715 (2012).","journal-title":"Dev. Cell"},{"key":"89989_CR5","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.yjmcc.2012.10.016","volume":"54","author":"RK Adapala","year":"2013","unstructured":"Adapala, R. K. et al. TRPV4 channels mediate cardiac fibroblast differentiation by integrating mechanical and soluble signals. J. Mol. Cell Cardiol. 54, 45\u201352 (2013).","journal-title":"J. Mol. Cell Cardiol."},{"key":"89989_CR6","doi-asserted-by":"publisher","first-page":"5225","DOI":"10.1172\/JCI75331","volume":"124","author":"SO Rahaman","year":"2014","unstructured":"Rahaman, S. O. et al. TRPV4 mediates myofibroblast differentiation and pulmonary fibrosis in mice. J. Clin. Investig. 124, 5225\u20135238 (2014).","journal-title":"J. Clin. Investig."},{"key":"89989_CR7","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1161\/CIRCRESAHA.109.216101","volume":"107","author":"M Dobaczewski","year":"2010","unstructured":"Dobaczewski, M. et al. Smad3 signaling critically regulates fibroblast phenotype and function in healing myocardial infarction. Circ. Res. 107, 418\u2013428 (2010).","journal-title":"Circ. Res."},{"key":"89989_CR8","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1038\/ncb1823","volume":"11","author":"Q Liu","year":"2009","unstructured":"Liu, Q., Busby, J. C. & Molkentin, J. D. Interaction between TAK1-TAB1-TAB2 and RCAN1-calcineurin defines a signalling nodal control point. Nat. Cell Biol. 11, 154\u2013161 (2009).","journal-title":"Nat. Cell Biol."},{"key":"89989_CR9","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1038\/75037","volume":"6","author":"D Zhang","year":"2000","unstructured":"Zhang, D. et al. TAK1 is activated in the myocardium after pressure overload and is sufficient to provoke heart failure in transgenic mice. Nat. Med. 6, 556\u2013563 (2000).","journal-title":"Nat. Med."},{"key":"89989_CR10","doi-asserted-by":"publisher","first-page":"H1871","DOI":"10.1152\/ajpheart.00387.2003","volume":"285","author":"J Wang","year":"2003","unstructured":"Wang, J., Chen, H., Seth, A. & McCulloch, C. A. Mechanical force regulation of myofibroblast differentiation in cardiac fibroblasts. Am. J. Physiol. Heart Circ. Physiol. 285, H1871-1881 (2003).","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"89989_CR11","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1161\/CIRCRESAHA.110.223172","volume":"107","author":"EM Small","year":"2010","unstructured":"Small, E. M. et al. Myocardin-related transcription factor-a controls myofibroblast activation and fibrosis in response to myocardial infarction. Circ. Res. 107, 294\u2013304 (2010).","journal-title":"Circ. Res."},{"key":"89989_CR12","doi-asserted-by":"publisher","first-page":"1306","DOI":"10.1161\/CIRCRESAHA.119.316162","volume":"127","author":"D Bugg","year":"2020","unstructured":"Bugg, D. et al. Infarct collagen topography regulates fibroblast fate via p38-yes-associated protein transcriptional enhanced associate domain signals. Circ. Res. 127, 1306\u20131322 (2020).","journal-title":"Circ. Res."},{"key":"89989_CR13","doi-asserted-by":"publisher","first-page":"ra100","DOI":"10.1126\/scisignal.2005262","volume":"7","author":"J Lauriol","year":"2014","unstructured":"Lauriol, J. et al. RhoA signaling in cardiomyocytes protects against stress-induced heart failure but facilitates cardiac fibrosis. Sci. Signal 7, ra100 (2014).","journal-title":"Sci. Signal"},{"key":"89989_CR14","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1161\/CIRCRESAHA.116.303577","volume":"119","author":"SD Prabhu","year":"2016","unstructured":"Prabhu, S. D. & Frangogiannis, N. G. The biological basis for cardiac repair after myocardial infarction: From inflammation to fibrosis. Circ. Res. 119, 91\u2013112 (2016).","journal-title":"Circ. Res."},{"key":"89989_CR15","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1016\/j.jacbts.2020.07.009","volume":"5","author":"J Francisco","year":"2020","unstructured":"Francisco, J. et al. Blockade of fibroblast YAP attenuates cardiac fibrosis and dysfunction through MRTF-A inhibition. JACC Basic Transl. Sci. 5, 931\u2013945 (2020).","journal-title":"JACC Basic Transl. Sci."},{"key":"89989_CR16","doi-asserted-by":"publisher","first-page":"C813","DOI":"10.1152\/ajpcell.00146.2019","volume":"317","author":"N Niranjan","year":"2019","unstructured":"Niranjan, N. et al. Sarcolipin overexpression impairs myogenic differentiation in Duchenne muscular dystrophy. Am. J. Physiol. Cell Physiol. 317, C813\u2013C824 (2019).","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"89989_CR17","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1161\/CIRCRESAHA.115.306624","volume":"117","author":"Y Yang","year":"2015","unstructured":"Yang, Y. et al. miR-206 mediates YAP-induced cardiac hypertrophy and survival. Circ. Res. 117, 891\u2013904 (2015).","journal-title":"Circ. Res."},{"key":"89989_CR18","doi-asserted-by":"publisher","first-page":"3977","DOI":"10.1074\/jbc.M112.436311","volume":"288","author":"DP Del Re","year":"2013","unstructured":"Del Re, D. P. et al. Yes-associated protein isoform 1 (Yap1) promotes cardiomyocyte survival and growth to protect against myocardial ischemic injury. J. Biol. Chem. 288, 3977\u20133988 (2013).","journal-title":"J. Biol. Chem."},{"key":"89989_CR19","doi-asserted-by":"publisher","first-page":"3315","DOI":"10.1038\/ncomms4315","volume":"5","author":"D Shao","year":"2014","unstructured":"Shao, D. et al. A functional interaction between Hippo-YAP signalling and FoxO1 mediates the oxidative stress response. Nat. Commun. 5, 3315 (2014).","journal-title":"Nat. Commun."},{"key":"89989_CR20","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1161\/CIRCRESAHA.116.308586","volume":"119","author":"T Matsuda","year":"2016","unstructured":"Matsuda, T. et al. NF2 activates hippo signaling and promotes ischemia\/reperfusion injury in the heart. Circ. Res. 119, 596\u2013606 (2016).","journal-title":"Circ. Res."},{"key":"89989_CR21","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.1172\/JCI17459","volume":"111","author":"S Yamamoto","year":"2003","unstructured":"Yamamoto, S. et al. Activation of Mst1 causes dilated cardiomyopathy by stimulating apoptosis without compensatory ventricular myocyte hypertrophy. J. Clin. Investig. 111, 1463\u20131474 (2003).","journal-title":"J. Clin. Investig."},{"key":"89989_CR22","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1161\/CIRCRESAHA.116.309202","volume":"119","author":"M Ackers-Johnson","year":"2016","unstructured":"Ackers-Johnson, M. et al. A simplified, Langendorff-free method for concomitant isolation of viable cardiac myocytes and nonmyocytes from the adult mouse heart. Circ. Res. 119, 909\u2013920 (2016).","journal-title":"Circ. Res."},{"key":"89989_CR23","doi-asserted-by":"publisher","first-page":"e003658","DOI":"10.1161\/CIRCHEARTFAILURE.116.003658","volume":"10","author":"T Matsuda","year":"2017","unstructured":"Matsuda, T. et al. H-Ras isoform mediates protection against pressure overload-induced cardiac dysfunction in part through activation of AKT. Circ. Heart Fail. 10, e003658 (2017).","journal-title":"Circ. Heart Fail."},{"key":"89989_CR24","doi-asserted-by":"publisher","first-page":"2139","DOI":"10.1242\/dev.079970","volume":"139","author":"A Acharya","year":"2012","unstructured":"Acharya, A. et al. The bHLH transcription factor Tcf21 is required for lineage-specific EMT of cardiac fibroblast progenitors. Development 139, 2139\u20132149 (2012).","journal-title":"Development"},{"key":"89989_CR25","doi-asserted-by":"publisher","first-page":"e1005155","DOI":"10.1371\/journal.pgen.1005155","volume":"11","author":"ST Nurnberg","year":"2015","unstructured":"Nurnberg, S. T. et al. Coronary artery disease associated transcription factor TCF21 regulates smooth muscle precursor cells that contribute to the fibrous cap. PLoS Genet. 11, e1005155 (2015).","journal-title":"PLoS Genet."},{"key":"89989_CR26","doi-asserted-by":"publisher","first-page":"3625","DOI":"10.1016\/j.celrep.2018.03.010","volume":"22","author":"T Xie","year":"2018","unstructured":"Xie, T. et al. Single-cell deconvolution of fibroblast heterogeneity in mouse pulmonary fibrosis. Cell Rep. 22, 3625\u20133640 (2018).","journal-title":"Cell Rep."},{"key":"89989_CR27","doi-asserted-by":"publisher","first-page":"e128722","DOI":"10.1172\/jci.insight.128722","volume":"4","author":"H Khalil","year":"2019","unstructured":"Khalil, H. et al. Cell-specific ablation of Hsp47 defines the collagen-producing cells in the injured heart. JCI Insight 4, e128722 (2019).","journal-title":"JCI Insight"},{"key":"89989_CR28","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.1101\/gad.192856.112","volume":"26","author":"Y Liu-Chittenden","year":"2012","unstructured":"Liu-Chittenden, Y. et al. Genetic and pharmacological disruption of the TEAD-YAP complex suppresses the oncogenic activity of YAP. Genes Dev. 26, 1300\u20131305 (2012).","journal-title":"Genes Dev."},{"key":"89989_CR29","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1161\/CIRCRESAHA.119.311148","volume":"125","author":"NG Frangogiannis","year":"2019","unstructured":"Frangogiannis, N. G. The extracellular matrix in ischemic and nonischemic heart failure. Circ. Res. 125, 117\u2013146 (2019).","journal-title":"Circ. Res."},{"key":"89989_CR30","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.1101\/gad.329763.119","volume":"33","author":"Y Xiao","year":"2019","unstructured":"Xiao, Y. et al. Hippo pathway deletion in adult resting cardiac fibroblasts initiates a cell state transition with spontaneous and self-sustaining fibrosis. Genes Dev. 33, 1491\u20131505 (2019).","journal-title":"Genes Dev."},{"key":"89989_CR31","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1007\/s12265-020-10006-7","volume":"14","author":"B Chen","year":"2020","unstructured":"Chen, B. & Frangogiannis, N. G. Chemokines in myocardial infarction. J. Cardiovasc. Transl. Res. 14, 35\u201352 (2020).","journal-title":"J. Cardiovasc. Transl. Res."},{"key":"89989_CR32","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1161\/CIRCULATIONAHA.106.646091","volume":"115","author":"NG Frangogiannis","year":"2007","unstructured":"Frangogiannis, N. G. et al. Critical role of monocyte chemoattractant protein-1\/CC chemokine ligand 2 in the pathogenesis of ischemic cardiomyopathy. Circulation 115, 584\u2013592 (2007).","journal-title":"Circulation"},{"key":"89989_CR33","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1161\/01.RES.0000163017.13772.3a","volume":"96","author":"O Dewald","year":"2005","unstructured":"Dewald, O. et al. CCL2\/Monocyte Chemoattractant Protein-1 regulates inflammatory responses critical to healing myocardial infarcts. Circ. Res. 96, 881\u2013889 (2005).","journal-title":"Circ. Res."},{"key":"89989_CR34","doi-asserted-by":"publisher","first-page":"3293","DOI":"10.1084\/jem.20170689","volume":"214","author":"A Anzai","year":"2017","unstructured":"Anzai, A. et al. The infarcted myocardium solicits GM-CSF for the detrimental oversupply of inflammatory leukocytes. J. Exp. Med. 214, 3293\u20133310 (2017).","journal-title":"J. Exp. Med."},{"key":"89989_CR35","doi-asserted-by":"publisher","first-page":"2038","DOI":"10.1161\/CIRCULATIONAHA.112.000116","volume":"127","author":"MD Majmudar","year":"2013","unstructured":"Majmudar, M. D. et al. Monocyte-directed RNAi targeting CCR2 improves infarct healing in atherosclerosis-prone mice. Circulation 127, 2038\u20132046 (2013).","journal-title":"Circulation"},{"key":"89989_CR36","doi-asserted-by":"publisher","first-page":"e97054","DOI":"10.1172\/jci.insight.97054","volume":"3","author":"A Willeford","year":"2018","unstructured":"Willeford, A. et al. CaMKIIdelta-mediated inflammatory gene expression and inflammasome activation in cardiomyocytes initiate inflammation and induce fibrosis. JCI Insight 3, e97054 (2018).","journal-title":"JCI Insight"},{"key":"89989_CR37","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1101\/gad.294348.116","volume":"31","author":"X Guo","year":"2017","unstructured":"Guo, X. et al. Single tumor-initiating cells evade immune clearance by recruiting type II macrophages. Genes Dev. 31, 247\u2013259 (2017).","journal-title":"Genes Dev."},{"key":"89989_CR38","doi-asserted-by":"publisher","first-page":"107990","DOI":"10.1016\/j.celrep.2020.107990","volume":"32","author":"M Liu","year":"2020","unstructured":"Liu, M. et al. Macrophage K63-linked ubiquitination of YAP promotes its nuclear localization and exacerbates atherosclerosis. Cell Rep. 32, 107990 (2020).","journal-title":"Cell Rep."},{"key":"89989_CR39","doi-asserted-by":"publisher","first-page":"1692","DOI":"10.1136\/gutjnl-2017-314061","volume":"67","author":"W Kim","year":"2018","unstructured":"Kim, W. et al. Hepatic Hippo signaling inhibits protumoural microenvironment to suppress hepatocellular carcinoma. Gut 67, 1692\u20131703 (2018).","journal-title":"Gut"},{"key":"89989_CR40","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1016\/j.cell.2015.12.029","volume":"164","author":"B Liu","year":"2016","unstructured":"Liu, B. et al. Toll receptor-mediated hippo signaling controls innate immunity in drosophila. Cell 164, 406\u2013419 (2016).","journal-title":"Cell"},{"key":"89989_CR41","doi-asserted-by":"publisher","first-page":"eaaj1757","DOI":"10.1126\/scisignal.aaj1757","volume":"11","author":"TJ Hagenbeek","year":"2018","unstructured":"Hagenbeek, T. J. et al. The Hippo pathway effector TAZ induces TEAD-dependent liver inflammation and tumors. Sci. Signal 11, eaaj1757 (2018).","journal-title":"Sci. Signal"},{"key":"89989_CR42","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1172\/JCI88759","volume":"127","author":"V Ramjee","year":"2017","unstructured":"Ramjee, V. et al. Epicardial YAP\/TAZ orchestrate an immunosuppressive response following myocardial infarction. J. Clin. Investig. 127, 899\u2013911 (2017).","journal-title":"J. Clin. Investig."},{"key":"89989_CR43","doi-asserted-by":"publisher","first-page":"13131","DOI":"10.1074\/jbc.RA119.008970","volume":"294","author":"J Francisco","year":"2019","unstructured":"Francisco, J. et al. The tumor suppressor RASSF1A modulates inflammation and injury in the reperfused murine myocardium. J. Biol. Chem. 294, 13131\u201313144 (2019).","journal-title":"J. Biol. Chem."},{"key":"89989_CR44","doi-asserted-by":"publisher","first-page":"e201900424","DOI":"10.26508\/lsa.201900424","volume":"3","author":"J Chen","year":"2020","unstructured":"Chen, J. et al. aYAP modRNA reduces cardiac inflammation and hypertrophy in a murine ischemia-reperfusion model. Life Sci. Alliance 3, e201900424 (2020).","journal-title":"Life Sci. Alliance"},{"key":"89989_CR45","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.1016\/j.celrep.2019.03.028","volume":"27","author":"X Zhou","year":"2019","unstructured":"Zhou, X. et al. YAP aggravates inflammatory bowel disease by regulating M1\/M2 macrophage polarization and gut microbial homeostasis. Cell Rep. 27, 1176\u20131189 (2019).","journal-title":"Cell Rep."},{"key":"89989_CR46","doi-asserted-by":"publisher","first-page":"4564","DOI":"10.1038\/s41467-018-07022-2","volume":"9","author":"Y Deng","year":"2018","unstructured":"Deng, Y. et al. Reciprocal inhibition of YAP\/TAZ and NF-kappaB regulates osteoarthritic cartilage degradation. Nat. Commun. 9, 4564 (2018).","journal-title":"Nat. Commun."},{"key":"89989_CR47","doi-asserted-by":"publisher","first-page":"2107","DOI":"10.1172\/JCI125014","volume":"130","author":"R LaCanna","year":"2019","unstructured":"LaCanna, R. et al. Yap\/Taz regulate alveolar regeneration and resolution of lung inflammation. J. Clin. Investig. 130, 2107\u20132122 (2019).","journal-title":"J. Clin. Investig."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-89989-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-89989-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-89989-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,3]],"date-time":"2022-12-03T08:20:10Z","timestamp":1670055610000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-89989-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,18]]},"references-count":47,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["89989"],"URL":"https:\/\/doi.org\/10.1038\/s41598-021-89989-5","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,18]]},"assertion":[{"value":"14 December 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 May 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 May 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"10553"}}